Cluster Headache Market, by Type (Episodic and Chronic), by Drug Type (Fast-acting Drugs, Long-term Drugs, and Short-term Drugs), by Route of Administration (Oral, Topical, Intravenous, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pha

Cluster Headache Market, by Type (Episodic and Chronic), by Drug Type (Fast-acting Drugs, Long-term Drugs, and Short-term Drugs), by Route of Administration (Oral, Topical, Intravenous, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cluster headache is one of the most severe type of headache, as it occurs in cyclical patterns or cluster periods. Cluster episodes, which last from weeks to months, are frequently followed by remission periods, during which the headache stops. For months, if not years, there are no headaches during remission. Cluster headache is most frequently experienced between the ages of puberty and middle age, but it can strike anyone at any time. Cluster headache is divided into two categories: episodic and chronic. Episodic cluster headache occurs on a regular basis for one week to a year, followed by a month or more of headache-free time. Chronic cluster headache regularly occurs for more than a year, followed by a headache-free period lasting less than a month.
A person with episodic cluster headache may develop chronic cluster headache and vice versa. One-sided soreness, restlessness, excessive tears, redness of the eye on the afflicted side, runny nose on the affected side, and others are some of the symptoms. The dilatation, or widening, of the blood arteries that feed blood to the brain and face causes cluster headache. The trigeminal nerve, which sends sensations from the face to the brain, is compressed by this dilatation.
Market Dynamics
Increasing prevalence of cluster headache is anticipated to drive the growth of global cluster headache market over the forecast period. For instance, according to the article published in the National Center for Biotechnology Information in April 2018, cluster headache is a primary headache that affects up to 0.1% of the population globally. Patients suffer cluster headache attacks up to eight times a day lasting 15 to 180 minutes. The male to female ratio is approximately 2.5: 1.
Key features of the study:
This report provides in-depth analysis of the global cluster headache market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cluster headache market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Zosano Pharma, Eli Lilly and Company, Lundbeck Seattle BioPharmaceutical, Winston Laboratories, GlaxoSmithKline plc., ElectroCore Medical LLC, Autonomic Technologies, Inc., AstraZeneca plc., Allergan plc., Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Sanofi, and AbbVie Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cluster headache market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cluster headache market
Detailed Segmentation:
Global Cluster Headache Market, By Type:
Episodic
Chronic
Global Cluster Headache Market, By Drug Type:
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
Global Cluster Headache Market, By Route of Administration:
Oral
Topical
Intravenous
Others
Global Cluster Headache Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Cluster Headache Market, By Region:
North America
By Type
Episodic
Chronic
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Type
Episodic
Chronic
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type
Episodic
Chronic
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Episodic
Chronic
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Type
Episodic
Chronic
By Drug Type
Fast-acting Drugs
Long-term Drugs
Short-term Drugs
By Route of Administration
Oral
Topical
Intravenous
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Zosano Pharma
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Eli Lilly and Company
Lundbeck Seattle BioPharmaceutical
Winston Laboratories
GlaxoSmithKline plc.
ElectroCore Medical LLC
Autonomic Technologies, Inc.
AstraZeneca plc.
Allergan PLC
Bayer AG
F. Hoffmann-La Roche Ltd
Novartis AG
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Sanofi
AbbVie Inc.
“*” marked represents similar segmentation in other categories in the respective section.